| | Intracameral triamcinolone may be viable PKP treatment
| | Topical, periocular, and/or systemic corticosteroids typically are used to treat corneal endothelial graft rejection. When those modalities fail, experience in a series of five eyes suggests intracameral triamcinolone acetonide may be worth considering. | |  |
|
|
| Dry eye a serious public health problem
| Condition affects patient quality of life, health-care resources, and economy
| | Ophthalmology Times | Considerable progress has been made in recent years in the understanding of the epidemiology of dry eye disease. Here, two doctors discuss some of the studies that have helped ophthalmologists understand the prevalence, burden, and risk factors of dry eye disease. They also highlight how improved diagnosis will have a significant effect on the quality of life of patients with dry eye. |
| | Artificial cornea useful in patients with multiple graft rejections
| Ongoing international multicenter study involving 250 eyes shows graft survival rate exceeds 95%
| | Ophthalmology Times | In patients who have suffered multiple immunologic graft rejections, the chance of providing good-quality vision is dramatically increased with a keratoprosthesis than another transplant. Patients who receive a keratoprosthesis have rapid visual return, a good quality of vision, and a high rate of graft survival. |
| | Prepare for hyperopic shift following DSAEK graft surgery
| | Ophthalmology Times | A retrospective study including 45 eyes that underwent Descemet's stripping automated endothelial keratoplasty (DSAEK) found an average refractive change of +0.88 D after surgery. That hyperopic shift after DSAEK has implications for management of patients undergoing cataract surgery simultaneously with or after DSAEK and for anticipating refractive outcomes in pseudophakic patients undergoing DSAEK. |
| | Vaccines may have future in ocular HZV and HPV
| | Ophthalmology Times | Vaccines may have a role in corneal and external ocular disease, specifically for herpes zoster virus and human papilloma virus infections, because of the successes of the vaccines in preventing systemic diseases. |
| | Optical coherence tomography a useful addition to clinical practice, doctor finds
| Noncontact device does not require pupil dilation, although learning curve is associated with its use
| | Ophthalmology Times | A proprietary device for optical coherence tomography (Visante, Carl Zeiss Meditec) seems to be a highly useful addition to clinical practice. The instrument, according to one physician, may be the best resource thus far to evaluate placement of intracorneal segments, femtosecond laser-enabled keratoplasty, and penetrating keratoplasty. |
|
| | TB4 can protect cornea against oxidative damage
| | Ophthalmology Times | Administering TB4 (Thymosin Beta 4, RegeneRx) up-regulates anti-oxidative enzymes in human corneal epithelial cells, helping to protect the cornea and resist oxidative damage, according to researchers. |
| | UV rays don't just damage skin
| | Ophthalmology Times | Prevent Blindness has dedicated May as UV Awareness Month in an effort to educate the public on the best way to protect their eyes. |
| | | Corneal implants okayed for use in Canada
| | Ophthalmology Times | Addition Technology has received regulatory clearance from Health Canada to market its corneal implants (Intacs) for keratoconus and myopia indications. |
|
|